Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

Clinical trial NCT05995236 · TERMINATED

Trial details

NCT number: NCT05995236
Sponsor: Methodist Health System
Status: TERMINATED
Study type: OBSERVATIONAL

Prostate Cancer

Start date: 2023-08-03
Primary completion: 2026-07-09
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.